Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Anemia, Aplastic × Tacrolimus × 90 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 13 Precursor Cell Lymphoblastic Leukemia-Lymphoma 9 Myelodysplastic Syndromes 9 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6 Hematologic Neoplasms 5 Primary Myelofibrosis 4 Lymphoma, Non-Hodgkin 4 Lymphoma 4 Anemia, Refractory, with Excess of Blasts 4 Myeloproliferative Disorders 3 Lymphoproliferative Disorders 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Lymphoid 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Leukemia, Biphenotypic, Acute 3 Leukemia 3 Hematologic Diseases 3 Preleukemia 2 Precancerous Conditions 2 Neoplasms by Histologic Type 2 Neoplasms 2 Myelodysplastic-Myeloproliferative Diseases 2 Lymphoma, Mantle-Cell 2 Lymphatic Diseases 2 Leukemia, Myeloid 2 Leukemia, B-Cell 2 Immunoproliferative Disorders 2 Immune System Diseases 2 Hodgkin Disease 2 Graft vs Host Disease 2

Interventions

Valganciclovir 1 Therapeutics 1 Polymerase Chain Reaction 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Antiviral Agents 1 11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡